Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Erectile dysfunction (ED), a common and highly treatable condition, affects millions of men, many starting to have symptoms ...

Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...

The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side effects than older drugs.

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

ACCORDINGLY. BACK TO YOU, MY FRIEND. THANKS, CORY. FOR MANY WOMEN, HOT FLASHES AND NIGHT SWEATS CAN MAKE MENOPAUSE A REAL CHALLENGE. THE FDA JUST APPROVED A NEW NON-HORMONAL DRUG TO HELP KOAT UNM ...

Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most effective weight loss medication yet. Retatrutide is a triple-agonist ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. US Army hypersonic missile ...